文献速递神经肌肉病

美国老年人群重症肌无力的流行病学研究:2006-2019年医疗保险索赔数据库纵向分析

Epidemiologic Study of Myasthenia Gravis in the Elderly US Population: A Longitudinal Analysis of the Medicare Claims Database, 2006-2019.
PubMed 文献 · Neurology · 2024-11-04

基于2006-2019年美国医疗保险按服务付费(FFS)索赔数据的回顾性纵向研究,65岁及以上人群MG期间患病率从81/10万升至119/10万(p<0.001),发病率从12.2/10万增至13.3/10万(p<0.05),全因死亡率保持稳定。

要点

  • 65岁及以上FFS覆盖人群MG患病率从2006-2007年81/10万升至2018-2019年119/10万(p<0.001)。
  • MG发病率从2008-2009年12.2/10万增至2018-2019年13.3/10万(p<0.05)。
  • MG受益人全因死亡率从6.26/100人年降至5.67/100人年,无显著差异(p=0.18)。

核心结论

  • 研究证实美国老年人群中MG患病率和发病率呈上升趋势,且部分亚组变化速率存在差异。

研究设计与样本

  • 回顾性纵向研究,使用2006-2019年医疗保险索赔数据,纳入65岁及以上、有至少1个月FFS A/B覆盖且无健康维护组织保险的受益人,按2年周期(2006-2007至2018-2019)汇总。
  • MG病例通过验证算法确认:每个2年周期内2次MG索赔,来自2次门诊就诊或1次住院加1次门诊就诊,间隔至少28天。

主要发现

  • MG期间患病率从2006-2007年81/10万升至2018-2019年119/10万(p<0.001),所有性别、年龄(65-69/70-74/75-79/80+)、种族/族裔(非裔美国人/亚裔/任何种族西班牙裔/非西班牙裔白人/其他)和普查区域(东北部/中西部/南部/西部)亚组均呈上升趋势。
  • MG发病率从2008-2009年12.2/10万增至2018-2019年13.3/10万(p<0.05);男性和女性、除75-79岁外所有年龄组、非西班牙裔白人、东北部/中西部/南部普查区域发病率上升趋势显著。
  • MG受益人全因死亡率从2006-2007年6.26/100人年变为2018-2019年5.67/100人年,无显著差异(p=0.18)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Epidemiologic studies suggest increasing incidence and prevalence of myasthenia gravis (MG) among the elderly population outside the United States. We aimed to provide an estimation of MG incidence and prevalence and their trend among the Medicare Fee-For-Service (FFS)-covered elderly US population. METHODS: We performed a retrospective longitudinal study using Medicare claims data (2006-2019). Study-eligible beneficiaries were aged 65 years and older, had at least 1 month of FFS Part A/B coverage, and were without any health maintenance organization insurance coverage. Study-eligible beneficiaries were aggregated into 2-year periods from 2006-2007 through 2018-2019. MG cases were ascertained using a validated algorithm of 2 MG claims within each 2-year period, from 2 outpatient office visits or a combination of 1 inpatient admission and 1 outpatient office visit, separated by ≥ 28 days. Period prevalence was calculated from MG-ascertained cases divided by FFS Part A/B beneficiaries and reported as cases per 100,000 population. Incident cases were determined among MG prevalent cases if the initial MG claim occurred in that period after a full calendar year since coverage initiation. Incidence was calculated as case counts per 100,000 at-risk beneficiary person-years (PYs) in each period excluding 2006-2007. Trends of prevalence and incidence over time were examined with Poisson regression. All-cause mortality of each 2-year period was calculated. RESULTS: The period prevalence of MG increased from 81 to 119 per 100,000 FFS A/B population from 2006-2007 to 2018-2019 (p < 0.001). Increasing trends of prevalence were observed in all sex (male/female), age (65-69/70-74/75-79/80+), race/ethnic (African American/Asian/Hispanics of any race/non-Hispanic White/other), and census region (Northeast/Midwest/South/West) subgroups. MG incidence increased from 12.2 to 13.3 per 100,000 PYs from 2008-2009 to 2018-2019 (p < 0.05). Increasing incidence trends were significant in the following subgroups: men and women; all age groups except 75-79 years; White non-Hispanic race; Northeast, Midwest, and South census regions. All-cause mortality among MG beneficiaries was stable from 6.26 deaths per 100 PYs in 2006-2007 to 5.67 in 2018-2019 (p = 0.18). DISCUSSION: Increasing trends in MG prevalence and incidence in the elderly US population, with variation in rates of certain subgroups, are confirmed in this 14-year period.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Bruckman D, Lee I, Schold JD, et al. Epidemiologic Study of Myasthenia Gravis in the Elderly US Population: A Longitudinal Analysis of the Medicare Claims Database, 2006-2019. Neurology. 2024. PMID: 39496108. doi:10.1212/WNL.0000000000210005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。